ClearBridge Investments, an investment management firm, published its “All Cap Growth Strategy” first quarter 2021 investor letter – a copy of which can be downloaded here. The ClearBridge All Cap Growth Strategy outperformed its Russell 3000 Growth Index benchmark during the first quarter. On an absolute basis, the Strategy had gains across eight of the 10 sectors in which it was invested (out of 11 sectors total). You can view the fund’s top 5 holdings to have a peek at their top bets for 2021.
In the Q1 2021 Investor Letter, the fund highlighted a few stocks and Biogen Inc. (NASDAQ:BIIB) is one of them. Biogen Inc. (NASDAQ:BIIB) is a biotechnology company. In the last three months, Biogen Inc. (NASDAQ:BIIB) stock gained 56%. Here is what the fund said:
“We like our biopharmaceutical positioning with Biogen shares moving higher on new patents for its Tecfidera multiple sclerosis treatment and in anticipation of the FDA’s decision on its aducanumab treatment for Alzheimer’s disease.”
Nestor Rizhniak/Shutterstock.com
In February, we had published an article revealing that Biogen Inc. (NASDAQ:BIIB) was one of the 10 cheap stocks to invest in.
In Q4 2020, the number of bullish hedge fund positions on Biogen Inc. (NASDAQ:BIIB) stock increased by about 7% from the previous quarter (see the chart here), so a number of other hedge fund managers believe in BIIB’s growth potential. Our calculations showed that Biogen Inc. (NASDAQ:BIIB) isn’t ranked among the 30 most popular stocks among hedge funds.
The top 10 stocks among hedge funds returned 231.2% between 2015 and 2020, and outperformed the S&P 500 Index ETFs by more than 126 percentage points. We know it sounds unbelievable. You have been dismissing our articles about top hedge fund stocks mostly because you were fed biased information by other media outlets about hedge funds’ poor performance. You could have doubled the size of your nest egg by investing in the top hedge fund stocks instead of dumb S&P 500 ETFs. Here you can watch our video about the top 5 hedge fund stocks right now. All of these stocks had positive returns in 2020.
At Insider Monkey, we scour multiple sources to uncover the next great investment idea. For example, an activist hedge fund wants to buy this $26 biotech stock for $50. So, we recommended a long position to our monthly premium newsletter subscribers. We go through lists like the 10 best battery stocks to pick the next Tesla that will deliver a 10x return. Even though we recommend positions in only a tiny fraction of the companies we analyze, we check out as many stocks as we can. We read hedge fund investor letters and listen to stock pitches at hedge fund conferences. You can subscribe to our free daily newsletter on our homepage.
Disclosure: None. This article is originally published at Insider Monkey.
